Adagene Inc.
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 19, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Sep 14, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Sep 10, 2026 | Chardan Capital | initiate | — → Buy | — | 47% |
| Apr 6, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Nov 24, 2025 | Guggenheim | initiate | — → Buy | $9 | 52% |
| Sep 18, 2025 | LUCID CAPITAL MARKETS | initiate | — → Buy | $9 | 34% |
| Aug 15, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| Aug 6, 2025 | Leerink Partners | initiate | — → Outperform | $7 | 50% |
| Apr 3, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Jan 27, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $8 | 44% |
| Sep 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Jul 22, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Jun 28, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Oct 4, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Sep 1, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Apr 21, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $5 | 44% |
| Mar 29, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $5 | 44% |
| Mar 21, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $5 | 44% |
| Jan 24, 2023 | Morgan Stanley | maintain | — → Overweight | $5 | 54% |
| Dec 7, 2022 | HC Wainwright & Co. | initiate | — → Buy | $5 | 44% |
| Sep 9, 2022 | Morgan Stanley | maintain | — → Overweight | $7 | 54% |
| Feb 1, 2022 | Morgan Stanley | maintain | — → Overweight | $15 | 54% |
| Jan 6, 2022 | Morgan Stanley | maintain | — → Overweight | $27 | 54% |
| Jul 16, 2021 | Morgan Stanley | maintain | — → Overweight | $33 | 54% |
| Jun 25, 2021 | China Renaissance | initiate | — → Buy | $40.57 | 58% |
| Mar 8, 2021 | Jefferies | initiate | — → Buy | $33 | 52% |
| Mar 8, 2021 | Morgan Stanley | initiate | — → Overweight | $34 | 54% |
No cross-platform signals in the last 90 days